Olet täällä

testosteroni

Anaboliset steroidit ja testosteroni

Anaboliset steroidit ovat testosteronin synteettisiä johdannaisia. Testosteroni on elimistön tärkein androgeeni, eli niin sanottu mieshormoni. Tässä tietoartikkelissa esitellään anabolisten ateroidien ja testosteronin vaikutusmekanismeista, käyttötarkoituksesta dopingaineena ja haittavaikutuksista.

[1] Davis S, Wahlin-Jacobsen S. Testosterone in women-the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980-92
 
[2] Kadi F. Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br J Pharmacol. 2008;154(3):522–528
 
[3] Huhtaniemi I. Androgeenit. Teoksessa: Välimäki M, Sane T, Dunkel L. Endokrinologia. 2009. Duodecim Oy
 
[4] Handelsman D. Commentary: Androgens and “anabolic steroids”: the one-headed janus. Endocrinology. 2011;152(5):1752-1754
 
[5] Frati P, Busardò FP, Cipolloni L, Dominicis ED, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13(1):146–59
 
[6] Kuhn CM. Anabolic Steroids. Recent Prog Horm Res. 2002; 57:411–34
 
[7] Kicman A. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521
 
[8] Hall RC, Hall RC. Abuse of supraphysiologic doses of anabolic steroids. South Med J. 2005;98(5):550–5
 
[9] Nieschlag E, Nieschlag S. Testosterone deficiency: a historical perspective. Asian J Androl. 2014; 16:161-168
 
[10] Nieschlag E, Nieschlag S. Endocrine history: The history of discovery, synthesis and development of testosterone for clinical use. European J Endocrinol. 2019; 180:6
 
[11] Davey R, Grossmann M. Androgen receptor structure, function and biology: From bench to bedside. Clin Biochem Rev. 2016;37(1):3–15
 
[12] Serra C, Bhasin S, Tangherliini F, Barton E, Ganno M, Zhang A, Shansky J, Vandenburgh H, Travison T, Jasuja R, Morssi C. The role of GH and IGF-1 mediating anabolic effects of testosterone on androgen-responsive muscle.
Endocrinology. 2011;152(1):193-206
 
[13] KELA. Lääkekorvausten saajat ja reseptitiedot- Testosteroni 2008-2019. 2020
 
[14] Handelsman D. Global trends in testosterone prescribing, 2000-20011: expanding the spectrum of prescription drug misuse. Med J Aust. 2013;199(8):548-51
 
[15] Gabrielsen J, Najari B, Alukal J, Eisenberg M. Trends in testosterone prescription and public health concerns. Urol Clin North Am. 2016;43(2):261-71
 
[16] Bahrke & Yesalis. Abuse of anabolic androgenic steroids and related substances in sport and exercise. Current Opinion in Pharmacology. 2004; 4: 614–620
 
[17] Seppälä & Karila. Suorituskykyyn vaikuttavien aineiden väärinkäyttö. Käytännön Lääkäri. 1996; 3: 129–135
 
[18] Wright S, Grogan S, Hunter G. Motivations for anabolic steroid use among bodybuilders. J Health Psych. 2000;5(4):566-571
 
[19] Kimergård A. A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences. J Subst Use. 2014;20(4):288-294
 
[20] Cohen J, Collins R, Darkes J. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007; 4:12
 
[21] McVeigh J, Bates G, Chandler M. Steroids and image enhancing drugs. 2014 Survey results. 2015. Public Health Wales, Liverpool John Moores University
 
[22] Pope H, Wood R, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement. Endocr Rev. 2014;35(3):341-375
 
[23] Pärssinen, Kujala, Vartiainen, Sarna & Seppälä. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. International Journal of Sports Medicine. 2000; 21: 225–227
 
[24] Horwitz H, Andersen J, Dalhoff K. Health consequences of androgenic anabolic steroid use. J Intern Med. 2019;285(3):333-340
 
[25] Taimela & Seppälä. Voimaharjoittelussa käytettävien anabolisten aineiden haitat. Suomen Lääkärilehti. 1994; 20–21: 2051–2061
 
[26] Karila, Hovatta, Seppälä (2004): Concomitant abuse of anabolic androgenic steroids and human chorion gonadotropin impairs spermatogenesis in power athletes. International Journal of Sports Medicine. 2004; 25: 257-263
 
[27] Kuhn CM. Anabolic Steroids. Recent Prog Horm Res. 2002; 57:411–34
 
[28] Büttner A, Thieme D. Side effects of anabolic androgenic steroids: Pathological findings and structure-activity relationships. Handb Exp Pharmacol. 2010;(195):459–84
 
[29] Van Amsterdam J, Opperhuizen A, Hartgens F. Adverse effects of anabolic-androgenic steroids. Regul Toxico Pharmacol. 2010;57(1):117-123
 
[30] Sarikaya H, Peters C, Schulz T, Schönfelder, Michna H. 2007. Biomedical Side Effects of Doping. International Symposium Munich, Germany. “Harmonising the Knowledge About Biomedical Side Effects of Doping” -Project of the European Union
 
[31] Kanayama, Hudson & Pope. Long-term psychiatric and medical consequences of anabolic–androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence. 2008; 98: 1–12
 
[32] Mäntysaari, Karila & Seppälä. Cardiovascular findings in power athletes abusing anabolic androgenic steroids. International Review of the Armed Forces Medical Services. 2005; 75: 12–15
 
[33] Thiblin, Mobini-Far & Frisk. Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine. Forensic Science International. 2009; 184: e7–e11
 
[34] Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. Rev Endo Metab Dis. 2015;16(3):199-211
 
[35] Hickson R, Ball K, Falduto M. Adverse effects of anabolic steroids. Med Toxic Adv Drug Exp. 1989;4(4):254-271
 
[36] Hope V, Harris R, McVeigh J, Cullen K, Smith J, Parry J, DeAngelis D, Ncube F. Risk of HIV and hepatitis B and C over time among men who inject image and performance enhancing drugs in England and Wales: Results from cross-sectional prevalence surveys 1992-2013. J Acquir Immune Defic Syndr. 2016:71(3):331-337
 
[37] Pärssinen & Seppälä. Steroid use and long-term health risks in former athletes. Sports Medicine. 2002; 32(2): 83–94
 
[38] Giammanco, Tabacchi, Giammanco, Di Majo & La Guardia. Testosterone and aggressiveness. Medical Science Monitor. 2005; 11(4): 136–145
 
[39] Kanayama G, Brower KJ, Wood RI, et al. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009; 104:1966–1978
 
[40] Ip E, Lu D, Barnet M, Tenerowicz M, Vo J, Perry P. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012;32(10):910–9
 
[41] Lundholm L, Käll K, Wallin S, Thiblin I. Use of anabolic androgenic steroids in substance abusers arrested for crime. Drug Alcohol Depend. 2010;111(3):222–6
 
[42] Lood Y, Eklund A, Garle M, Ahlner J. Anabolic androgenic steroids in police cases in Sweden 1999–2009. Forensic Sci Int. 2012;219(1–3):199–204
 
[43] Lundholm L, Frisell T, Lichtenstein P, Långström N. Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men. Addiction. 2015;110(1):100–8 101 
 
[44] Onakomaiya M, Henderson L. Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors. Psychopharmacology. 2016;233(4):549–569